Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pharmacokinetics of NNC0537-1482 in Participants With Various Degrees of Renal Function
NCT07808788Phase 1Not yet recruiting
- Sponsor
- Novo Nordisk
- Start
- Sep 2026
- Primary completion
- Jul 2027
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of NNC0537-1482 in chronic kidney disease (CKD), sponsored by Novo Nordisk. Primary endpoint: Area under the plasma concentration-time curve from 0 hours to the time of the last quantifiable concentration at Day 36. Planned start Sep 2026; status: not yet recruiting.
02
Drugs
NNC0537-1482
03
Conditions
chronic kidney disease (CKD)
Beyond the preview
Go deeper on NCT07808788.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07808788.